Italian rider Diego Ulissi looks set to make his return to competition at the Trittico Lombardo after three months without racing due to elevated levels of salbutamol which he tested positive for in the Giro d’Italia.

Lampre-Merida announced today that, after having carefully reviewed documents from Ulissi's attorney, and considering the rules of the Movement for a Credible Cycling (MPCC), they will allow him to resume competing, "while waiting for further evidence, currently still late, from the UCI and WADA".

Ulissi, who won two stages at the Giro, was told that he has tested positive on stage 11 and he contained 1900ng/l of the drug, with the UCI level being 1000ng/l.

Lampre had declared the use of an asthma inhaler by Ulissi to the anti-doping authorities, and Ulissi insisted he had only taken the recommended dose during the race.